Opus Genetics (IRD) Interest Coverage Ratio (QoQ) (2011 - 2026)
Opus Genetics (IRD) Interest Coverage Ratio (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Opus Genetics | 3.27 Mn | -56.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.87% |
| Dec 31, 2025 | -330.64% |
| Jun 30, 2022 | 5.16% |
| Mar 31, 2022 | 57.67% |
| Dec 31, 2020 | -4,748.35% |
| Sep 30, 2020 | -52.67% |
| Jun 30, 2020 | 54.53% |
| Mar 31, 2020 | -101.52% |
| Dec 31, 2019 | 8,026.07% |
| Sep 30, 2019 | 24.73% |
| Jun 30, 2019 | 24.83% |
| Mar 31, 2019 | 99.96% |
| Dec 31, 2018 | -211,721.24% |
| Sep 30, 2018 | 9.06% |
| Jun 30, 2018 | 17.77% |
| Mar 31, 2018 | 99.91% |
| Dec 31, 2017 | -189,530.88% |
| Sep 30, 2017 | 4.18% |
| Jun 30, 2017 | -4.75% |
| Mar 31, 2017 | 99.96% |